5-chlorosalicylic acid structure
|
Common Name | 5-chlorosalicylic acid | ||
---|---|---|---|---|
CAS Number | 321-14-2 | Molecular Weight | 172.566 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | 320.5±27.0 °C at 760 mmHg | |
Molecular Formula | C7H5ClO3 | Melting Point | 171-172 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 147.6±23.7 °C | |
Symbol |
GHS06 |
Signal Word | Danger |
Name | 5-chlorosalicylic acid |
---|---|
Synonym | More Synonyms |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 320.5±27.0 °C at 760 mmHg |
Melting Point | 171-172 °C(lit.) |
Molecular Formula | C7H5ClO3 |
Molecular Weight | 172.566 |
Flash Point | 147.6±23.7 °C |
Exact Mass | 171.992722 |
PSA | 57.53000 |
LogP | 3.42 |
Vapour Pressure | 0.0±0.7 mmHg at 25°C |
Index of Refraction | 1.630 |
Water Solubility | 1 g/L (20 ºC) |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H301-H315-H319 |
Precautionary Statements | P301 + P310-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
Hazard Codes | Xn:Harmful |
Risk Phrases | R22;R36/37/38 |
Safety Phrases | S26-S36-S37/39 |
RIDADR | UN 2811 6.1/PG 3 |
WGK Germany | 3 |
RTECS | VO2080000 |
Packaging Group | III |
Hazard Class | 6.1 |
HS Code | 29182990 |
Precursor 9 | |
---|---|
DownStream 10 | |
HS Code | 2918290000 |
---|---|
Summary | HS: 2918290000 other carboxylic acids with phenol function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids and their derivatives Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) VAT:17.0% MFN tariff:6.5% General tariff:30.0% |
Predicting human serum albumin affinity of interleukin-8 (CXCL8) inhibitors by 3D-QSPR approach.
J. Med. Chem. 48 , 2469-79, (2005) A novel class of 2-(R)-phenylpropionamides has been recently reported to inhibit in vitro and in vivo interleukin-8 (CXCL8)-induced biological activities. These CXCL8 inhibitors are derivatives of phe... |
|
Structure-activity relationship of salicylic acid derivatives on inhibition of TNF-α dependent NFκB activity: Implication on anti-inflammatory effect of N-(5-chlorosalicyloyl)phenethylamine against experimental colitis.
Eur. J. Med. Chem. 48 , 36-44, (2012) To develop a more potent NFκB inhibitor from salicylic acid which is known to inhibit activity of NFκB, a transcription factor regulating genes involved in immunity, inflammation and tumorigenesis, de... |
|
In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II.
Bioorg. Med. Chem. 16 , 9101-5, (2008) The inhibition of two human cytosolic carbonic anhydrase (hCA, EC 4.2.1.1) isozymes, hCA I and II, with a series of salicylic acid derivatives was investigated by using the esterase method with 4-nitr... |
5-Chlorosalicyclic acid |
5-chloro-2-hydroxy-benzoic acid |
Benzoic acid, 5-chloro-2-hydroxy- |
5-chlorosalicylic acid |
EINECS 206-283-9 |
Salicylic acid,5-chloro |
2-Hydroxy-5-chlorobenzoic acid |
tert-butyl carbazate |
5-Chloro-2-hydroxybenzoic acid |
MFCD00002457 |
5 CSA |
Benzoic acid,5-chloro-2-hydroxy |
5-chloro-salicylic acid |